Indications and uses
To help support the repair & regeneration of articulations & joints
To help support the repair & regeneration of articulations & joints
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Anti-Interleukin-1 3 9X 200K, Ankle articulation 6X 200K, Beta endorphin 8 9X 200K, bFibroblast Growth Factor 8 9X 200K, Calcaneal tendon 200K, Hip articulation 6X 200K, Knee articulation 7X 200K, Liver 6X 200K, Transforming Growth Factor-1 7C 30K, Transformin Growth Factor-3 7C 30K,
| Anti-Interleukin-1 | Anti-inflammation |
| Ankle articulation | Regeneration |
| Beta endorphin | Pain relief |
| bFibroblast Growth Factor | Regeneration |
| Calcaneal tendon | Regeneration |
| Hip articulation | Regeneration |
| Knee articulation | Regeneration |
| Liver | Drainage |
| Transforming Growth Factor-1 | Immune support |
| Transformin Growth Factor-3 | Regeneration |
To help support the repair & regeneration of articulations & joints
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
Keep this and all medicines out of reach of children.
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Alcohol and Water
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
ITEM: VPC0031
NDC 63776-037-14
Homeopathic remedy
Articula
• To help support the repair & regeneration of articulations & joints
Oral spray
30ml 1 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Articula
30 mL
1 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0031
NDC: 63776-037-14
INDICATIONS:
To help support the repair & regeneratin of articulations & joints
DIRECTIONS:
1-3 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-037-14 | 2024-01-30 | C162847 | 48780-1 | 1030e365-3e01-111a-e063-dadaa90a10e2 | Articula |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-037-14 | Articula | 1 in 1 BOX | SPRAY | 1 | 5 | |
| 63776-037-14 | Articula | 30 mL in 1 BOTTLE, SPRAY | SPRAY | 30 | 5 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-037 | ARTICULA (ANTI-INTERLEUKIN-1.ALPHA. IMMUNOGLOBULIN G RABBIT, BOS TAURUS ANKLE JOINT, SUS SCROFA ANKLE JOINT, METENKEFALIN, ERSOFERMIN, BOS TAURUS ACHILLES TENDON, SUS SCROFA ACHILLES TENDON, BOS TAURUS HIP JOINT, SUS SCROFA HIP JOINT, BOS TAURUS KNEE JOINT, SUS SCROFA KNEE JOINT, BEEF LIVER, PORK LIVER, TRANSFORMING GROWTH FACTOR BETA-1, AVOTERMIN) SPRAY [VIATREXX BIO INCORPORATED] | 5 | Legacy NDC, 2 package rows | 20221201_e666d44e-d569-d9d9-e99f-afe6d2deca90.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE INGREDIENT | ML4QRZ1HCL | 1 | |
| Avotermin | ACTIVE INGREDIENT | 2Q1GS25JWN | 1 | |
| Beef Liver | ACTIVE INGREDIENT | W8N8R55022 | 1 | |
| Bos Taurus Achilles Tendon | ACTIVE INGREDIENT | EH4O8312JK | 1 | |
| Bos Taurus Ankle Joint | ACTIVE INGREDIENT | 63Z8OTG0HU | 1 | |
| Bos Taurus Hip Joint | ACTIVE INGREDIENT | Y8426REN4E | 1 | |
| Bos Taurus Knee Joint | ACTIVE INGREDIENT | 4O31PJ9AE1 | 1 | |
| Ersofermin | ACTIVE INGREDIENT | 1NWT5SW3NW | 1 | |
| Metenkefalin | ACTIVE INGREDIENT | 9JEZ9OD3AS | 1 | |
| Pork Liver | ACTIVE INGREDIENT | 6EC706HI7F | 1 | |
| Sus Scrofa Achilles Tendon | ACTIVE INGREDIENT | QYH0674GPR | 1 | |
| Sus Scrofa Ankle Joint | ACTIVE INGREDIENT | 654134QUOV | 1 | |
| Sus Scrofa Hip Joint | ACTIVE INGREDIENT | 519062UA90 | 1 | |
| Sus Scrofa Knee Joint | ACTIVE INGREDIENT | 109E3VZB62 | 1 | |
| Transforming Growth Factor Beta-1 | ACTIVE INGREDIENT | T7D25J14LT | 1 | |
| Anti-interleukin-1.alpha. Immunoglobulin G Rabbit | ACTIVE MOIETY | ML4QRZ1HCL | 1 | |
| Avotermin | ACTIVE MOIETY | 2Q1GS25JWN | 1 | |
| Beef Liver | ACTIVE MOIETY | W8N8R55022 | 1 | |
| Bos Taurus Achilles Tendon | ACTIVE MOIETY | EH4O8312JK | 1 | |
| Bos Taurus Ankle Joint | ACTIVE MOIETY | 63Z8OTG0HU | 1 | |
| Bos Taurus Hip Joint | ACTIVE MOIETY | Y8426REN4E | 1 | |
| Bos Taurus Knee Joint | ACTIVE MOIETY | 4O31PJ9AE1 | 1 | |
| Ersofermin | ACTIVE MOIETY | 1NWT5SW3NW | 1 | |
| Metenkefalin | ACTIVE MOIETY | 9JEZ9OD3AS | 1 | |
| Pork Liver | ACTIVE MOIETY | 6EC706HI7F | 1 | |
| Sus Scrofa Achilles Tendon | ACTIVE MOIETY | QYH0674GPR | 1 | |
| Sus Scrofa Ankle Joint | ACTIVE MOIETY | 654134QUOV | 1 | |
| Sus Scrofa Hip Joint | ACTIVE MOIETY | 519062UA90 | 1 | |
| Sus Scrofa Knee Joint | ACTIVE MOIETY | 109E3VZB62 | 1 | |
| Transforming Growth Factor Beta-1 | ACTIVE MOIETY | T7D25J14LT | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-037 | 63776-037-14 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb4ad79-af66-84e1-e053-2a95a90ab919 | e666d44e-d569-d9d9-e99f-afe6d2deca90 | 2022-11-30 | Warnings | eeb4ad79-af66-84e1-e053-2a95a90ab919 e666d44e-d569-d9d9-e99f-afe6d2deca90 |